Latest UCLA's Jonsson Comprehensive Cancer Center Stories
CHICAGO, April 21 /PRNewswire/ -- A clinical study underway at Rex Cancer Center of Wakefield will evaluate the use of telemonitoring in managing administration of Gleevec, a drug developed and manufactured by Novartis to treat chronic myeloid leukemia.
Researchers unveil scientific results from siRNA Phase I clinical trial in cancer patients.
New results from a major initiative on the quality of cancer care in the United States show that patients with a common type of colon cancer -- especially older patients -- often are not treated as aggressively with chemotherapy as research shows is necessary to improve survival.
A combination of two targeted therapies already shown to be effective in breast cancer packs an effective one-two punch against a subset of gastric cancers that have a specific genetic mutation
In ongoing work to identify how genes interact with social environments to impact human health, UCLA researchers have discovered what they describe as a biochemical link between misery and death.
Physicians and scientists agree: If we cannot entirely prevent cancer, the next best thing is to find it earlier to augment the chances of a successful fight.
Specific chemical modifications to proteins called histones, which are found in the nucleus of cells and act as spools around which DNA is wound, can be used to predict prognosis and response to treatment in subsets patients with pancreatic cancer.
Study may result in new and more effective therapies.
UT Southwestern Medical Center researchers have found that a naturally occurring protein â€” transforming growth factor beta1 (TGF-ÃŸ1) â€” which normally suppresses the growth of cancer cells, causes a rebound effect after a prolonged exposure.
Society's Medal of Honor to be Awarded on November 19 LOS ANGELES, Nov.
- A volcanic mudflow.